SNWV
HealthcareSANUWAVE Health, Inc. Common Stock
Live · XNAS · May 9, Close
What's Moving SNWV Today?
No stock-specific AI insight has been generated for SNWV yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
SNWV News
20 articles- biote Corp. (BTMD) Q1 Earnings and Revenues Lag EstimatesYahoo Finance·May 6, 2026
- Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial ResultsYahoo Finance·May 6, 2026
- Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should KnowYahoo Finance·May 5, 2026
- Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseYahoo Finance·May 1, 2026
- How The SANUWAVE Health (SNWV) Story Is Shifting After The Latest Price Target ResetYahoo Finance·Apr 27, 2026
- Sanuwave Health (SNWV) Slipped as CMS Dropped the Coverage LimitYahoo Finance·Apr 20, 2026
- Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-YearGlobeNewswire Inc.·Apr 16, 2026
- How The SANUWAVE Health (SNWV) Investment Narrative Is Resetting After A Lower Price TargetYahoo Finance·Apr 13, 2026
- How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV)Yahoo Finance·Mar 29, 2026
- SANUWAVE Health, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 28, 2026
- Sanuwave Health Q4 Earnings Call HighlightsMarketbeat·Mar 27, 2026
- Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025GlobeNewswire Inc.·Mar 26, 2026
- Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial ResultsYahoo Finance·Mar 20, 2026
- SANUWAVE Health (NASDAQ:SNWV) investors are sitting on a loss of 63% if they invested five years agoYahoo Finance·Feb 10, 2026
- Deep Sail Capital Partners’ Investment Thesis for Sanuwave Health (SNWV)Yahoo Finance·Feb 5, 2026
- SANUWAVE Health, Inc. (NASDAQ:SNWV) Has Found A Path To ProfitabilityYahoo Finance·Jan 14, 2026
- Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year RevenueYahoo Finance·Jan 9, 2026
- 3 Growth Stocks With Strong Insider ConfidenceYahoo Finance·Dec 18, 2025
- Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceYahoo Finance·Dec 10, 2025
- Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupplyYahoo Finance·Dec 8, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.